RxDoctor Payments Data

Steven Seese, DO

Psychiatry · Dover, OHNPI 1053846725

Payments from drug & device makers

$1,669in general payments, 2019–2025

Across 100 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$322
  • Corium, LLC$211
  • Otsuka America Pharmaceutical, Inc.$206
  • Axsome Therapeutics, Inc.$190
  • Neurocrine Biosciences, Inc.$147
  • Vanda Pharmaceuticals Inc.$116
  • plus $477 from 11 others

What the payments were for

  • Food & beverage$1,669100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,669 in reported general payments places this provider in the 75th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$35,590
Medicare patients
82
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate34$292,331
VraylarCariprazine Hcl47$64,940
AuvelityDextromethorphan Hbr/Bupropion17$17,710
TrintellixVortioxetine Hydrobromide15$8,244
BelsomraSuvorexant18$7,671
Vilazodone Hcl36$5,279
Lurasidone Hcl21$4,876
Aripiprazole111$4,307
Bupropion XlBupropion Hcl126$3,574
Duloxetine Hcl113$2,730
Ramelteon25$2,518
Venlafaxine Hcl ErVenlafaxine Hcl118$2,396
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$2,033
Quetiapine Fumarate80$1,567
Escitalopram Oxalate96$1,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$147$292,33134 claims
AbbVieVraylar$322$64,94047 claims
Axsome Therapeutics, Inc.Auvelity$190$17,71017 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$30$8,24415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Dover

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →